Archive


Category: Advanz Pharma

  • UK fines Advanz £100m for raising thyroid drug price tenfold

    The UK has levied another big fine for anticompetitive activity in the pharma market in a fortnight, with Advanz Pharma and former owners on the hook for more than £100 million ($140 million) after increasing the price of a thyroid disease drug by 1,110% over an eight-year period. The Competition and Markets Authority (CMA) said […]

  • Health Innovators: Graeme Duncan, Advanz Pharma

    In this episode of our Health Innovators series, Paul Tunnah interviews Graeme Duncan, CEO of specialty pharmaceutical company Advanz Pharma. Graeme discusses his career in the life sciences industry and how Advanz Pharma positions itself as the go-to partner for companies commercialising complex medicines in Europe. Graeme also shares how COVID-19 has impacted Advanz Pharma’s […]